Literature DB >> 12395884

Genetic bases of autoimmune hepatitis.

Albert J Czaja1, Derek G Doherty, Peter T Donaldson.   

Abstract

Our goal was to review the hypotheses in evolution that promise to elucidate the genetic bases of autoimmune hepatitis. DRB1*0301 and DRB1*0401 are the principal risk factors in Britain and the United States. Other susceptibility alleles in different ethnic groups commonly share the same or a similar motif at the critical DRbeta71 position of the HLA class II molecule. Disease severity may be determined by the number of alleles encoding lysine at the DRbeta1 position, the density of dimers presenting antigen, and the avidity of T-cell receptors for the displayed antigen. Concurrence on the same or different chromosomes of other nonspecific autoimmune promoters may also contribute. A negatively charged residue at the P4 position of antigenic peptides is preferred for binding to the disease-susceptibility alleles, and this complex may be recognized by promiscuous T cells. We conclude that autoimmune hepatitis is a model by which to study the genetic bases of autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12395884     DOI: 10.1023/a:1020166605016

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  91 in total

1.  A gender gap in autoimmunity.

Authors:  C C Whitacre; S C Reingold; P A O'Looney
Journal:  Science       Date:  1999-02-26       Impact factor: 47.728

2.  T-cell receptor V beta selectivity in T-cell clones alloreactive to HLA-Dw14.

Authors:  K Yamanaka; W W Kwok; E M Mickelson; S Masewicz; G T Nepom
Journal:  Hum Immunol       Date:  1992-01       Impact factor: 2.850

Review 3.  HLA class II transgenic mice as models of human diseases.

Authors:  V Taneja; C S David
Journal:  Immunol Rev       Date:  1999-06       Impact factor: 12.988

4.  Cutting edge: persistent fetal microchimerism in T lymphocytes is associated with HLA-DQA1*0501: implications in autoimmunity.

Authors:  N C Lambert; P C Evans; T L Hashizumi; S Maloney; T Gooley; D E Furst; J L Nelson
Journal:  J Immunol       Date:  2000-06-01       Impact factor: 5.422

5.  Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen.

Authors:  K C Garcia; M Degano; L R Pease; M Huang; P A Peterson; L Teyton; I A Wilson
Journal:  Science       Date:  1998-02-20       Impact factor: 47.728

Review 6.  A unified hypothesis for the complex genetics of HLA associations with IDDM.

Authors:  G T Nepom
Journal:  Diabetes       Date:  1990-10       Impact factor: 9.461

7.  Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis.

Authors:  A J Czaja; M D Strettell; L J Thomson; P J Santrach; S B Moore; P T Donaldson; R Williams
Journal:  Hepatology       Date:  1997-02       Impact factor: 17.425

8.  Significance of HLA DR4 in type 1 autoimmune hepatitis.

Authors:  A J Czaja; H A Carpenter; P J Santrach; S B Moore
Journal:  Gastroenterology       Date:  1993-11       Impact factor: 22.682

Review 9.  HLA and insulin-dependent diabetes. A protective perspective.

Authors:  M J Sheehy
Journal:  Diabetes       Date:  1992-02       Impact factor: 9.461

10.  Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis.

Authors:  D G Doherty; P T Donaldson; J A Underhill; J M Farrant; A Duthie; G Mieli-Vergani; I G McFarlane; P J Johnson; A L Eddleston; A P Mowat
Journal:  Hepatology       Date:  1994-03       Impact factor: 17.425

View more
  22 in total

Review 1.  Emerging opportunities for site-specific molecular and cellular interventions in autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2010-01-27       Impact factor: 3.199

Review 2.  Transitioning from Idiopathic to Explainable Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2015-05-22       Impact factor: 3.199

3.  Type 1 autoimmune hepatitis in Taiwan: diagnosis using the revised criteria of the International Autoimmune Hepatitis Group.

Authors:  Lok-Beng Koay; Ching-Yih Lin; Sun-Lung Tsai; Chuan Lee; Ching-Nan Lin; Ming-Juen Sheu; Hsing-Tao Kuo; Chi-Shu Sun
Journal:  Dig Dis Sci       Date:  2006-10-20       Impact factor: 3.199

4.  HLA DRB1 Alleles Discriminate the Manifestation of Autoimmune Hepatitis as Type 1 or Type 2 in North Indian Population.

Authors:  Navchetan Kaur; Ranjana W Minz; Shashi Anand; Biman Saikia; Ritu Aggarwal; Ashim Das; Babu R Thapa; Yogesh K Chawla
Journal:  J Clin Exp Hepatol       Date:  2013-12-16

5.  Association of HLA-DR14 with the treatment response in Japanese patients with autoimmune hepatitis.

Authors:  Yoshiyuki Suzuki; Kenji Ikeda; Miharu Hirakawa; Yusuke Kawamura; Hiromi Yatsuji; Hitomi Sezaki; Tetsuya Hosaka; Norio Akuta; Masahiro Kobayashi; Fumitaka Suzuki; Satoshi Saitoh; Yasuji Arase; Mariko Kobayashi; Yuzo Miyakawa; Hiromitsu Kumada
Journal:  Dig Dis Sci       Date:  2010-01-22       Impact factor: 3.199

Review 6.  Pathogenesis and clinical significance of liver injury in celiac disease.

Authors:  Umberto Volta
Journal:  Clin Rev Allergy Immunol       Date:  2009-02       Impact factor: 8.667

Review 7.  A comparative review of HLA associations with hepatitis B and C viral infections across global populations.

Authors:  Rashmi Singh; Rashmi Kaul; Anil Kaul; Khalid Khan
Journal:  World J Gastroenterol       Date:  2007-03-28       Impact factor: 5.742

Review 8.  Autoimmune hepatitis in children.

Authors:  Robert H Squires
Journal:  Curr Gastroenterol Rep       Date:  2004-06

9.  Frequency and significance of antibodies to chromatin in autoimmune hepatitis.

Authors:  Albert J Czaja; Zakera Shums; Walter L Binder; Stephen J Lewis; Vicki J Nelson; Gary L Norman
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

10.  Long-term treatment outcomes for autoimmune hepatitis in Korea.

Authors:  Jae Sook Kil; Joon Hyoek Lee; A-Reum Han; Ja Young Kang; Hye Jin Won; Han Young Jung; Hyun Min Lim; Geum-Youn Gwak; Moon Seok Choi; Kwang Cheol Koh; Seung Woon Paik; Byung Chul Yoo
Journal:  J Korean Med Sci       Date:  2009-12-29       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.